These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30126822)

  • 1. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.
    Allaire M; Rekik S; Layese R; Mumana A; Guyot E; Nkontchou G; Bourcier V; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Sutter O; Audureau E; Seror O; Nault JC
    Dig Liver Dis; 2019 Jan; 51(1):86-94. PubMed ID: 30126822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.
    N'Kontchou G; Aout M; Laurent A; Nahon P; Ganne-Carrié N; Grando V; Baghad I; Roulot D; Trinchet JC; Sellier N; Cherqui D; Vicaut E; Beaugrand M; Seror O
    J Hepatol; 2012 Jan; 56(1):160-6. PubMed ID: 21703186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
    Alitti C; Rode A; Trillaud H; Merle P; Blanc JF; Blaise L; Demory A; Nkontchou G; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Petit A; Seror O; Sutter O; Nault JC
    Liver Int; 2024 Jun; 44(6):1363-1372. PubMed ID: 38436538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
    Boros C; Sutter O; Cauchy F; Ganne-Carrié N; Nahon P; N'kontchou G; Ziol M; Grando V; Demory A; Blaise L; Dondero F; Durand F; Soubrane O; Lesurtel M; Laurent A; Seror O; Nault JC
    Liver Int; 2024 Jun; 44(6):1464-1473. PubMed ID: 38581233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma.
    Chai Y; Li K; Zhang C; Chen S; Ma K
    BMC Cancer; 2019 May; 19(1):497. PubMed ID: 31133001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
    Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
    World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
    Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
    Pompili M; Saviano A; de Matthaeis N; Cucchetti A; Ardito F; Federico B; Brunello F; Pinna AD; Giorgio A; Giulini SM; De Sio I; Torzilli G; Fornari F; Capussotti L; Guglielmi A; Piscaglia F; Aldrighetti L; Caturelli E; Calise F; Nuzzo G; Rapaccini GL; Giuliante F
    J Hepatol; 2013 Jul; 59(1):89-97. PubMed ID: 23523578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices.
    Zhang K; Jiang L; Jia Z; Zhang Y; He R; Ding Z; Mu Y
    Dig Dis Sci; 2015 May; 60(5):1490-501. PubMed ID: 25431044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma.
    Machi J; Bueno RS; Wong LL
    World J Surg; 2005 Nov; 29(11):1364-73. PubMed ID: 16240062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.